Adial Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.71-$4.16 |
Market Cap | $4.7M |
Shares Short | 60,591 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.94 |
News
See moreYahoo Finance • 3 days ago
Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
Yahoo Finance • 17 days ago
Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
About
CEO | Mr. Cary John Claiborne MBA |
Address | 4870 Sadler Road, Glen Allen, VA, United States, 23060 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
